Biotech

Proteomics International Laboratories Ltd (ASX:PIQ) Pitt Street Research Life Sciences Conference

🕔9/19/2024 8:25:05 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to attendees at the Pitt Street Research Life Sciences Conference, Sydney on 19 September 2024.

Read Full Article

Invion Limited (ASX:IVX) Prostate Cancer Trial Results

🕔9/18/2024 4:14:59 PM

Invion Limited (ASX:IVX) wishes to announce that RMW Cho Group Limited (RMWC), the licensor of the Photosoft(TM) technology, has successfully completed a Phase II prostate cancer trial (ACTRN12621000633886) using a sublingual (under the tongue) formulation of INV043.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of Director

🕔9/16/2024 8:20:36 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, is pleased to announce the appointment of James Williams to its Board as an independent nonexecutive director, effective 16 September 2024.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Groundbreaking Results for Type 1 Diabetes and Kidney Health

🕔8/23/2024 9:01:43 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce groundbreaking results showing the PromarkerD predictive test can predict renal decline in type 1 diabetes.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) June 2024 Quarterly Activities Report

🕔7/30/2024 8:23:31 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to provide the following update on its business activities for the three months to 30 June 2024.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Eurobio Scientific to sell PromarkerD DKD Test in France

🕔6/24/2024 8:15:55 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce that Eurobio Scientific has been appointed to distribute its PromarkerD predictive test for diabetic kidney disease in France.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Appoints Medical Devices Sales Agency for Europe

🕔6/17/2024 8:22:54 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce it has engaged the medical device sales agency, Growth Medics B.V., to assist with the identification and selection of EU alliance partners for its PromarkerD predictive test for diabetic kidney disease.

Read Full Article